Standard BioTools Stockholders Approve Merger with SomaLogic
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced that its stockholders voted to approve all proposals required to be approved in connection with the pending merger with SomaLogic (Nasdaq:SLGC) at its Special Meeting of Stockholders.
Related news for (LAB)
- Today’s Top Performers: MoBot’s Market Review 10/14/25 04:00 AM
- Today’s Top Performers: MoBot’s Market Review 08/22/25 09:00 AM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/22/25 08:00 AM
- Today’s Top Performers: MoBot’s Market Review 06/23/25 09:00 AM
- Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
